A preclinical study showed that V-9302 could selectively block Gln uptake by TNBC cells, promote the activation of CD4 + T cells and CD8 + T cells, and reduce the level of Treg in a TNBC mouse model
Source: Professor Erwin Loh A minor scientific clarification: there is no recognized hormone, receptor, or therapeutic class called GLP-3. Retatrutide is a triple receptor agonist targeting the GLP-1 receptor, GIP receptor, and glucagon receptor
Upadacitinib in Crohns disease
Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma
We believe that providing researchers with a reliable, consistent, and ultra-pure product is our most important contribution to the scientific community
4 Cardiometabolic markers improved alongside the weight loss